Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Two different teams from the Medical Sciences Division have received a share of $14 million in funding from the Chan Zuckerberg Initiative as one of 29 projects that will explore emerging ideas regarding the role of inflammation in disease.

None

 

Two different teams from across Medical Sciences have been awarded a grant from the Chan Zuckerberg Initiative.

Associate Professor Mathilda Mommersteeg, Professor Paul Riley,and Professor Robin Choudhury will use their award to perform single cell analysis of inflammation during heart regeneration. Professor Mark Coles, Dr Calliope Dendrou, and Dr Anita Milicic will combine their expertise to create the first map of adjuvant-induced inflammation on tissues from diverse ethnic groups and build a unique resource that will inform more inclusive global vaccine design and development.

While inflammation is a natural defense that helps our bodies maintain a healthy state, chronic inflammation results in harmful diseases such as asthma, arthritis, and heart disease, and can also play a role in organ failure, neurodegenerative diseases like Alzheimer's, and many other conditions such as COVID-19.

The CZI welcomed 80 researchers to work on the two-year pilot projects, 75 percent of which are led by early-career scientists within six years of starting their independent position. Grantee teams are made up of two to three investigators with distinct areas of expertise and they represent 11 countries. 

Read full stories

Professor Mark Coles, Dr Calliope Dendrou, and Dr Anita Milicic research is explained in full on their departmental websites:

- The Jenner Institute

- The Wellcome Centre for Human Genetics

- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences

Associate Professor Mathilda Mommersteeg, Professor Paul Riley,and Professor Robin Choudhury research is explained more fully here:

- Department of Physiology, Anatomy and Genetics

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.